CG
BIB icon

Cutler Group’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Cutler Group’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-600
Closed -$1K – 3580
2023
Q1 		$1K Buy
+600
New +$33.9K ﹤0.01% 3341
2022
Q4 		– Sell
-2,800
Closed -$25K – 4401
2022
Q3 		$25K Sell
2,800
-400
-13% -$21.3K ﹤0.01% 2427
2022
Q2 		$14K Buy
3,200
+1,300
+68% +$66.1K ﹤0.01% 2931
2022
Q1 		$4K Buy
+1,900
New +$117K ﹤0.01% 4240
2021
Q4 		– Sell
-7,100
Closed -$80K – 5377
2021
Q3 		$80K Buy
7,100
+6,100
+610% +$617K ﹤0.01% 2102
2021
Q2 		$1K Buy
1,000
+600
+150% +$52.4K ﹤0.01% 5204
2021
Q1 		$4K Buy
+400
New +$37.7K ﹤0.01% 4473
2020
Q4 		– Sell
-600
Closed -$1K – 4796
2020
Q3 		$1K Sell
600
-3,700
-86% -$262K ﹤0.01% 4253
2020
Q2 		$3K Buy
4,300
+1,100
+34% +$70.2K ﹤0.01% 3565
2020
Q1 		$32K Buy
+3,200
New +$178K ﹤0.01% 2000
2019
Q4 		– Sell
-2,300
Closed -$5K – 3981
2019
Q3 		$5K Sell
2,300
-15,100
-87% -$716K ﹤0.01% 2986
2019
Q2 		$10K Buy
17,400
+7,800
+81% +$388K ﹤0.01% 2652
2019
Q1 		$14K Buy
+9,600
New +$517K ﹤0.01% 2257
2018
Q2 		– Sell
-2,700
Closed -$5K – 4197
2018
Q1 		$5K Sell
2,700
-9,500
-78% -$569K ﹤0.01% 3245
2017
Q4 		$5K Sell
12,200
-7,500
-38% -$423K ﹤0.01% 3582
2017
Q3 		$20K Buy
19,700
+300
+2% +$17.1K ﹤0.01% 3128
2017
Q2 		$78K Sell
19,400
-3,100
-14% -$151K ﹤0.01% 2070
2017
Q1 		$63K Sell
22,500
-5,700
-20% -$265K ﹤0.01% 2162
2016
Q4 		$112K Sell
28,200
-2,400
-8% -$102K ﹤0.01% 1807
2016
Q3 		$57K Buy
30,600
+17,200
+128% +$817K ﹤0.01% 2331
2016
Q2 		$33K Buy
13,400
+100
+0.8% +$4.31K ﹤0.01% 2786
2016
Q1 		$54K Sell
13,300
-1,500
-10% -$66.3K ﹤0.01% 2238
2015
Q4 		$110K Buy
+14,800
New +$989K 0.01% 1667

Other funds holding BIB

TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
WWM
Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Cutler Group's BIB Position: Q3 2023 in Review

Cutler Group sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2023, closing a stake of 400 shares — an estimated $20.6K sold.

Cutler Group first reported a position in BIB in Q2 2016 and held it in 20 quarters. The position peaked at $94K in Q3 2021. 21 funds tracked by Wall St. Rank hold BIB as of Q3 2023.

  • Cutler Group reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 400 ProShares Ultra NASDAQ Biotechnology shares in Q3 2023, an estimated $20.6K.
  • Cutler Group first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2016 and held it in 20 quarters.
  • Cutler Group's ProShares Ultra NASDAQ Biotechnology position peaked at $94K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.